Procter & Gamble’s (PG) Outperform Rating Reaffirmed at Royal Bank Of Canada

Procter & Gamble (NYSE:PG)‘s stock had its “outperform” rating restated by equities research analysts at Royal Bank Of Canada in a report released on Tuesday, Benzinga reports. They presently have a $166.00 price objective on the stock. Royal Bank Of Canada’s price objective suggests a potential upside of 4.68% from the stock’s previous close.

PG has been the subject of a number of other reports. Bank of America lowered their target price on Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research note on Friday, July 10th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, September 21st. Jefferies Financial Group upped their price target on Procter & Gamble from $177.00 to $179.00 and gave the stock a “buy” rating in a research report on Friday, June 26th. Evercore raised Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 price target for the company in a research report on Tuesday, October 6th. Finally, Barclays upped their price target on Procter & Gamble from $146.00 to $152.00 and gave the stock an “equal weight” rating in a research report on Tuesday, July 21st. Fourteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $162.20.

Procter & Gamble Trading Up 0.6%

Shares of Procter & Gamble stock traded up $0.89 during trading on Tuesday, hitting $158.58. 1,626,714 shares of the company were exchanged, compared to its average volume of 9,661,187. The firm has a market capitalization of $368.33 billion, a P/E ratio of 23.94, a price-to-earnings-growth ratio of 3.96 and a beta of 0.39. Procter & Gamble has a 1-year low of $137.62 and a 1-year high of $167.25. The firm’s fifty day moving average price is $147.11 and its 200 day moving average price is $146.62. The company has a debt-to-equity ratio of 0.43, a current ratio of 0.68 and a quick ratio of 0.47.

Procter & Gamble (NYSE:PG) last posted its earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. The business had revenue of $21.20 billion during the quarter, compared to analysts’ expectations of $21.38 billion. During the same period in the prior year, the business earned $1.48 EPS. Procter & Gamble’s revenue for the quarter was up 1.5% compared to the same quarter last year. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. As a group, sell-side analysts expect that Procter & Gamble will post 6.98 earnings per share for the current fiscal year.

Insider Activity

In other Procter & Gamble news, insider Marc Pritchard sold 4,030 shares of the company’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total transaction of $579,473.70. Following the completion of the transaction, the insider owned 187,001 shares of the company’s stock, valued at $26,888,873.79. This represents a 2.11% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Matthew Janzaruk sold 359 shares of the company’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $145.24, for a total value of $52,141.16. Following the transaction, the chief accounting officer directly owned 1,271 shares of the company’s stock, valued at approximately $184,600.04. This trade represents a 22.02% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 15,135 shares of company stock worth $2,189,970. 0.23% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Procter & Gamble

Several large investors have recently made changes to their positions in the stock. BlackRock Inc. bought a new position in shares of Procter & Gamble in the second quarter worth $27,862,105,000. State Street Corp increased its position in shares of Procter & Gamble by 1.0% in the second quarter. State Street Corp now owns 102,216,308 shares of the company’s stock worth $14,988,999,000 after purchasing an additional 965,461 shares during the period. Bank of America Corp DE bought a new position in shares of Procter & Gamble in the second quarter worth $3,850,628,000. Bank of New York Mellon Corp bought a new position in shares of Procter & Gamble in the second quarter worth $2,281,505,000. Finally, Dimensional Fund Advisors LP increased its position in shares of Procter & Gamble by 2.6% in the first quarter. Dimensional Fund Advisors LP now owns 11,797,916 shares of the company’s stock worth $1,704,182,000 after purchasing an additional 300,280 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Procter & Gamble raised its dividend for the 70th consecutive year, reinforcing its status as a premier income stock and supporting investor confidence in the durability of its cash flows. The Ultimate Dividend Growth Stock to Buy With $100 Right Now
• Positive Sentiment: Royal Bank of Canada reaffirmed its “outperform” rating and assigned a $166 price target, implying roughly 4.7% upside from the cited share price. The endorsement suggests confidence in PG’s defensive business model and earnings outlook. Benzinga analyst-rating report
• Positive Sentiment: Analysts and financial commentators highlighted PG’s innovation strategy, including brand investment, artificial-intelligence capabilities and productivity initiatives. These efforts could improve market share and revive organic sales growth over the long term. Procter & Gamble’s Innovation Push
• Positive Sentiment: A new Head & Shoulders Scalp Care Collection uses targeted, clinically tested formulations for different scalp-health needs, providing another example of PG’s effort to premiumize and refresh established brands. Why Is Procter & Gamble Refreshing Its Scalp Care Playbook Now?
• Neutral Sentiment: PG’s fiscal first-quarter results are scheduled for October 22. Preview coverage is centered on whether improving product volumes can offset pricing pressure, with investors watching organic sales, margins and management’s outlook closely. Procter & Gamble Earnings Preview
• Negative Sentiment: PG’s dividend yield is less attractive than Nike’s after Nike’s steep share-price decline, which may encourage income investors to compare alternatives. This is a relative-valuation concern rather than a change to PG’s dividend policy. Nike Now Yields More Than Procter & Gamble

Procter & Gamble Company Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.